The company said the approval will allow it to increase supply by an additional 7,000 Annovera rings.
Annovera, a ring-shaped vaginal system with hormones used to prevent pregnancy, was approved by the FDA in August 2018.
TherapeuticsMD shares were up nearly 34% in recent early Friday morning trading.
Price: 3.10, Change: +0.83, Percent Change: +36.34